A tumbler promotion tied to one of South Korea's most painful historical anniversaries cost the company's Korean CEO his job ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results